Innoveren Scientific, Inc.
DelistedCIK 1591165fmd_1N4CCZSA9JXR4BP049XVWHGQSVManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2014 to Sep 30, 2023, 39 periods
| Line item | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 0 | 0 | – | 0 | 8 | 8 | 2 | 2 | 0 |
| Cost of revenue | 0 | 0 | – | 0 | 2 | 2 | 1 | 1 | 0 |
| Gross profit | 0 | 0 | – | 0 | 6 | 6 | 1 | 1 | 0 |
| Research and development | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 2 |
| Selling, general and administrative | – | 5 | 5 | 6 | 5 | – | – | – | – |
| Total operating expenses | 3 | 6 | 13 | 6 | 10 | 37 | 8 | 6 | 5 |
| Compensation and benefits | – | – | – | – | 4 | 9 | 3 | 2 | 1 |
| Operating income | (3) | (6) | (13) | (6) | (4) | (31) | (7) | (5) | (5) |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| Other non-operating income (expense) | – | – | – | (0) | (0) | 1 | 1 | 0 | (5) |
| Income tax expense | 0 | 0 | – | – | – | – | – | – | – |
| Net income from continuing operations | – | (6) | (13) | (6) | (5) | – | – | – | – |
| Net income | (3) | (7) | (16) | (6) | (4) | (30) | (6) | (5) | (10) |
| Net income to common shareholders | – | – | – | – | (4) | (33) | (7) | (5) | (10) |